4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-25-004923
Options or other derivatives
- Chief Executive Officer acquired 666,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gros David-Alexandre C · Chief Executive Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-10 | Grant or award : show line 1 in the form Stock Option (right to buy) | +600,000 | 600,000 | D |
| 2025-01-10 | Grant or award : show line 2 in the form Restricted Stock Units | +66,500 | 66,500 | D |
Loading xslF345X05/ownership.xml…